C2i Genomics, Riken Genesis to expand AI-powered whole-genome MRD cancer detection technology across Japan

Trump signs order to use AI to accelerate pediatric cancer research

President Trump has signed an executive order to use artificial intelligence to accelerate research in pediatric cancers.

October 03, 2025

Vol.51 No.36

By Claire Marie Porter

In Brief

UC Davis Health and UCLA co-lead $16M study of AI use in breast cancer diagnosis

UC Davis Health and UCLA are co-leading a newly funded national clinical trial to evaluate whether AI can help radiologists interpret screening mammograms more accurately. The goal is to improve breast cancer detection and reduce unnecessary callbacks and anxiety for patients.

September 26, 2025

Vol.51 No.35

In Brief

Casey Graves appointed general manager of clinical solutions at ConcertAI

ConcertAI named Casey Graves general manager of Clinical Solutions. In this role, Graves will drive growth and innovation in real-world data and AI solutions for oncology research and clinical care, accelerating advances that improve outcomes for patients and healthcare providers.

September 19, 2025

Vol.51 No.34

In Brief

Zephyr AI appoints Allen Chao as CEO, acquires Aster Insights

Allen Chao was named CEO of Zephyr AI, a company focused on utilizing artificial intelligence to accelerate drug development.

September 19, 2025

Vol.51 No.34

In Brief

Javier J. Zulueta joins Qure.ai as CMO

Qure.ai has appointed Javier J. Zulueta, previously professor of medicine at the Icahn School of Medicine at Mount Sinai in New York and pulmonary division chief at Mount Sinai Morningside Hospital, as chief medical officer for pulmonology.

September 19, 2025

Vol.51 No.34

Clinical Roundup

How AI will transform mental health support for breast cancer patients, narrative review paper details

Researchers from UVA Cancer Center, the University of Virginia School of Medicine, and Inova Peterson Life with Cancer detail the many ways artificial intelligence could help ensure patients receive the support they need.

September 19, 2025

Vol.51 No.34

C2i Genomics, Riken Genesis to expand AI-powered whole-genome MRD cancer detection technology across Japan

YOU MAY BE INTERESTED IN

Trump signs order to use AI to accelerate pediatric cancer research

UC Davis Health and UCLA co-lead $16M study of AI use in breast cancer diagnosis

Casey Graves appointed general manager of clinical solutions at ConcertAI

Zephyr AI appoints Allen Chao as CEO, acquires Aster Insights

Javier J. Zulueta joins Qure.ai as CMO

How AI will transform mental health support for breast cancer patients, narrative review paper details

Renew today!

Subscriber content

Never miss an issue!

Login